视网膜静脉阻塞的诊断与治疗研究进展

Research progress of the diagnosis and treatment for retinal vein occlusion

视网膜静脉阻塞(retinal vein occlusion,RVO)是一种常见的视网膜血管疾病,是致盲的主要原因之一。近年来有关RVO的诊断及治疗措施等都有了一些新的认识和进步,特别是在治疗上有了一些新的研究,即玻璃体腔注射曲安奈德(triamcinolone acetonide,TA)、地塞米松植入物(Ozurdex)和抗血管内皮生长因子(vascular endothelial growth factor,VEGF)药物在RVO的应用。本文就近年来有关RVO的诊断及治疗研究进展综述如下。

Retinal vein occlusion （RVO） is a common vascular disease of the retina and is one of the main reasons for blindness. In recent years, there have been some new understanding about the diagnosis and treatment of the disease, especially some new researches about treatment,for example , in the therapy of the intravitreal injection of triamcinolone acetonide and anti-VEGFs as well as dexamethasone implant （Ozurdex）. This article will make a brief summarization of the progress about the diagnosis and treatment of RVO.